|Title:||Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis||Authors:||Nguyen, Nam Nhat
Ho, Dung Si
Nguyen, Hung Song
Ho, Dang Khanh Ngan
|Keywords:||Antidiabetic medication;COVID-19;Type 2 diabetes mellitus||Issue Date:||Jun-2022||Publisher:||W B SAUNDERS CO-ELSEVIER||Journal Volume:||131||Source:||Metabolism: clinical and experimental||Abstract:||
Diabetes is an independent predictor of poor outcomes in patients with COVID-19. We compared the effects of the preadmission use of antidiabetic medications on the in-hospital mortality of patients with COVID-19 having type 2 diabetes.
|Appears in Collections:||食品科學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.